CVS announced Thursday that it is now offering a lower cost alternative to the EpiPen with its generic version, Adrenaclick. The new auto-injector will be available to patients for $109.99 for a two-pack at all locations.
“Patients with life-threatening allergies need immediate access to injectable epinephrine. But over time, the brand-name epinephrine auto-injector pens that make it easy to quickly and safely administer the medication have become increasingly expensive.” CVS said in a news release.
The generic product is authorized and a Food and Drug Administration-approved device with the same active ingredient as other epinephrine auto-injector devices.
CVS suggests to current users of the EpiPen to speak to their doctors to see if the new product is an alternative, as well as checking with insurance companies to make sure the product is covered.